Workshop

Name: 19th WorldMEN Meeting
Start: 2025-06-16
End: 2025-06-17
Location: Renaissance Hotel (Alameda Santos, 2233 - Jardim Paulista)

16/06/2025 (Segunda-feira)

	Sala 1
07:45	07:45 - 08:00 Welcome Introduction ANA HOFF Chair MARIA LUISA BRANDI Chair
08:00	08:00 - 08:40 Plenary Session Effective tools to expand worldwide collaborations. Examples of effective alliances. LUCIANA NAVES Chair ANA HOFF Chair PAULO M. HOFF Chair KRISTI ALEXANDRAKI Presenter MARIA LUISA BRANDI Presenter 08:30 - 08:40 Discussion
08:40	08:40 - 10:10 Symposium Paraganglioma/Pheochromocytoma MADSON ALMEIDA Chair 08:40 - 08:50 Unmet needs MERCEDES ROBLEDO Speaker 08:50 - 09:10 Update on genetics of paragangliomas PATRICIA DAHIA Speaker 09:10 - 09:30 Personalized management of pheochromocytomas and paragangliomas LAUREN FISHBEIN Speaker 09:30 - 09:50 Systemic treatment of metastatic pheochromocytomas and paragangliomas CAMILO JIMENEZ Speaker 09:50 - 10:10 Discussion
10:10	10:10 - 10:40 Coffee Break Poster Discussions
10:40	10:40 - 12:20 Symposium Pituitary MÔNICA GADELHA Chair ANDREA GLEZER Chair 10:40 - 10:50 Unmet needs LUCIANA NAVES Speaker 10:50 - 11:05 Genetics of familial isolated pituitary tumors ALBERT BECKERS Speaker 11:05 - 11:20 Genetics of pediatric pituitary tumors CONSTANTINE STRATAKIS Speaker 11:20 - 11:35 Consensus guidelines for the diagnosis and management of pituitary adenomas in childhood and adolescence – a summary MARTA KORBONITS Speaker 11:35 - 11:50 Genetic basis of non-functioning pituitary tumors: Insights into tumorigenesis and progression RAFAEL LOCH BATISTA Speaker 11:50 - 12:20 Discussion
12:20	12:20 - 13:00 Sponsored Lecture Lilly \| The role of RET inhibitors in the treatment of advanced thyroid cancers FERNANDA VAISMAN Speaker
13:00	13:00 - 13:30 Break Poster Discussions
13:30	13:30 - 14:30 Oral Presentations .Oral Presentations ROBERT F. GAGEL Chair ELIZABETH G. GRUBBS Chair 13:30 - 13:40 Thyrosine Kinase Inhibitors for Advanced Medullary Thyroid Cancer: Insights from a Multicenter Cohort EVELIN CAVALCANTE FARIAS Presenter 13:40 - 13:45 Discussion 13:45 - 13:55 Comparison of Clinical Features and Outcomes Among Patients with MEN 2A Syndrome and RET Codon 634 Pathogenic Variants SARAH HAMIDI Presenter 13:55 - 14:00 Discussion 14:00 - 14:10 Mahvash Disease RAMON MARCELINO DO NASCIMENTO Presenter 14:10 - 14:15 Discussion
14:30	14:30 - 16:00 Symposium MEN2 Syndrome ANA LUIZA MAIA Chair RUI MACIEL Chair ROBERT F. GAGEL Chair 14:30 - 14:40 Unmet needs STEVEN WAGUESPACK Speaker 14:40 - 15:00 A critical review of the 2015 ATA Risk Stratification of RET mutations and timing for prophylactic thyroidectomy. Time for change? ELIZABETH G. GRUBBS Speaker 15:00 - 15:20 Insights from proteomic profiling of medullary thyroid cancer. WAYNE MILES Speaker 15:20 - 15:40 From normal C cell to MTC YE LEI Speaker 15:40 - 16:00 Discussion
16:00	16:00 - 16:20 Coffee Break Poster Discussions
16:20	16:20 - 17:10 Panel New American Thyroid Association Guideline for Advanced Medullary Thyroid Cancer ELIZABETH G. GRUBBS Chair MIMI HU Speaker ANA HOFF Speaker MARK ZAFEREO Speaker
17:10	17:10 - 18:00 Symposium Advances in Bilateral Macronodular Adrenocortical Disease (BMAD) CONSTANTINE STRATAKIS Chair ANA CLAUDIA LATRONICO Chair BERENICE MENDONÇA Chair 17:10 - 17:30 A Global Approach to the Long-Term follow-up of 17 Brazilian Families with Bilateral Macronodular Adrenal Disease MARIA CANDIDA FRAGOSO Speaker 17:30 - 17:50 The role of KDM1A and other genetic alterations associated with BMAD JEROME BERTHERAT Speaker 17:50 - 18:00 Discussion
18:00

Legenda

Welcome
Plenary Session
Symposium
Coffee Break
Sponsored Lecture
Break
Oral Presentations
Panel

17/06/2025 (Terça-feira)

	Sala 1
08:00	08:00 - 09:35 Symposium Parathyroid Diseases FABIO MONTENEGRO Chair MARISE LAZARETTI CASTRO Chair 08:00 - 08:15 The FIRMO parathyroid medal MARIA LUISA BRANDI Speaker 08:15 - 08:30 PHPT - advances in diagnosis and management ALIYA KHAN Speaker 08:30 - 08:45 Genetics of parathyroid neoplasia ANDREW ARNOLD Speaker 08:45 - 09:00 Advances in the treatment of post-surgical hypoparathyroidism MARIA LUISA BRANDI Speaker 09:00 - 09:15 Parathyroid cancer – MD Anderson experience NAIFA BUSAIDY Speaker 09:15 - 09:35 Discussion
09:35	09:35 - 10:05 Coffee Break Poster Discussions
10:05	10:05 - 11:20 Symposium Pancreatic Neuroendocrine Tumors MARK LEWIS Chair RICARDO JUREIDINI Chair MARIA IGNEZ BRAGHIROLI Chair 10:05 - 10:15 Unmet needs NANCY PERRIER Speaker 10:15 - 10:30 Predicting and preventing PNETs SAMIR HANASH Speaker 10:30 - 10:45 Surgical management of PNETs in MEN1 MENNO VRIENS Speaker 10:45 - 11:00 The role of precision medicine in the management of advanced PNETS JAMES YAO Speaker 11:00 - 11:20 Discussion
11:20	11:20 - 12:20 Symposium Treatment of Pancreatic Neuroendocrine Tumors – Beyond traditional surgery and targeted therapy PAULO M. HOFF Chair NANCY PERRIER Chair LUIZ TENÓRIO SIQUEIRA Chair 11:20 - 11:35 A new era in management of PNETs NIRAV THOSANI Speaker 11:35 - 11:50 PNET: Radionuclide therapy - Current experience and perspectives JAMES YAO Speaker 11:50 - 12:05 Update in liver transplantation for metastatic PNET RODRIGO VIANNA Speaker 12:05 - 12:20 Discussion
12:20	12:20 - 13:00 Sponsored Lecture IPSEN \| Neuroendocrine Tumors: challenges and advances in treatment landscape. DANIEL BULZICO Chair PEDRO USON Speaker
13:00	13:00 - 13:30 Break Poster Discussions
13:30	13:30 - 14:15 Oral Presentations Oral Presentations STEVEN WAGUESPACK Chair NANCY PERRIER Chair 13:30 - 13:40 Phenotypic Distinctions Between MEN1 Mutation-Positive and -Negative Probands: Insights from a Large Cohort and Development of a Predictive Online Tool DELMAR MUNIZ LOURENCO JUNIOR Presenter 13:40 - 13:45 Discussion 13:45 - 13:55 Methylome profiling of MEN1 assocaited GEP-NETs reveals functional heterogeneity and a β-cell subtype with high GHRH expression ZIYUAN LIU Presenter 13:55 - 14:00 Discussion 14:00 - 14:10 Multicenter Brazilian Experience with Temozolomide in Aggressive Pituitary Tumors ⁠ISABELLE PINHEIRO AMARO DE MAGALHÃES Presenter 14:10 - 14:15 Discussion
14:15	14:15 - 15:45 Symposium MEN 1 Syndrome RAJESH V. THAKKER Chair DELMAR MUNIZ LOURENCO JUNIOR Chair 14:15 - 14:35 Update in genetics of MEN1 SUNITA AGARWAL Speaker 14:35 - 14:55 The role of epigenetics in PNET development and as a potential therapeutic target KATE LINES Speaker 14:55 - 15:15 Unilateral clearance versus subtotal or total parathyroidectomy NANCY PERRIER Speaker 15:15 - 15:45 Discussion
15:45	15:45 - 16:15 Coffee Break Poster Discussions
16:15	16:15 - 16:45 Sponsored Lecture MSD \| Targeting HIF pathway in tumors associated to VHL syndrome MADSON ALMEIDA Speaker
16:45	16:45 - 17:45 Plenary Session MEN1 Guidelines MARIA LUISA BRANDI Chair RAJESH V. THAKKER Chair OMAIR SHARIQ Presenter RAJESH V. THAKKER Presenter
17:45	17:45 - 18:00 Meeting Summary and Awards Perspectives
18:00